Showing results (121-130 of 170) with videos related to

Sort By:
Pageof 17
Andrology|January 7, 2022
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadismAnthony DelConte, Kongnara Papangkorn, Kilyoung Kim, et al.
Cancers|February 24, 2024
Filamin A Is a Prognostic Serum Biomarker for Differentiating Benign Prostatic Hyperplasia from Prostate Cancer in Caucasian and African American MenNischal Mahaveer Chand, Poornima K Tekumalla, Matt T Rosenberg, et al.
The Canadian Journal of Urology|April 20, 2024
Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathwaysDavid E Crawford, David Albala, Marc B Garnick, et al.
Clinical Cardiology|May 5, 2016
Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA)David I Feldman, Miguel Cainzos-Achirica, Kevin L Billups, et al.
Sexual Medicine Reviews|June 27, 2024
Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposiumRaymond C Rosen, Martin Miner, Arthur L Burnett, et al.
Cardiovascular Diagnosis and Therapy|September 24, 2020
Cardiovascular/stroke risk predictive calculators: a comparison between statistical and machine learning modelsAnkush Jamthikar, Deep Gupta, Luca Saba, et al.
Medical & Biological Engineering & Computing|February 6, 2021
Wilson disease tissue classification and characterization using seven artificial intelligence models embedded with 3D optimization paradigm on a weak training brain magnetic resonance imaging datasets: a supercomputer applicationMohit Agarwal, Luca Saba, Suneet K Gupta, et al.
Mayo Clinic Proceedings|August 8, 2024
The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular DiseaseTobias S Köhler, Robert A Kloner, Raymond C Rosen, et al.
The Journal of Sexual Medicine|December 26, 2023
Princeton IV consensus guidelines: PDE5 inhibitors and cardiac healthRobert A Kloner, Arthur L Burnett, Martin Miner, et al.
The Canadian Journal of Urology|June 26, 2017
Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. studyClaus G Roehrborn, Jack Barkin, Steven N Gange, et al.
Pageof 17